You may find attached the announcement

As of November 28, 2022, the shares of the company "LAVIPHARM S.A." (GRS246003008) are traded on the ATHEX ex-rights in terms of 10.01868413773180 new (CR) shares for every 1 old (CR) share held - with issue of 170,588,235 new CR shares - at an issue price of €0.34 per share. The rights' trading period is set from December 1, 2022, to December 9, 2022 (included). The rights' subscription period is set from December 1, 2022, to December 14, 2022 (included).

See the announcement.

Notification of change in the composition of the Board of Directors

TERNA ENERGY FINANCE S.A (hereinafter, the “Company”)

Information regarding the resolutions of the repeat Bondholders Meeting of the common bond loan of an amount of €150,000,000 of the Company (hereinafter, the “CBL”)